THB 35.5
(2.9%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 20.99 Billion | 43.25 Billion | 10.5 Billion | 2.43 Billion | 13.08 Billion | 18.31 Billion |
Net Income | 19.44 Billion | 42.02 Billion | 13.06 Billion | -2.59 Billion | 6.51 Billion | 10.38 Billion |
Depreciation & Amortization | 7.79 Billion | 7.74 Billion | 7.42 Billion | 7.55 Billion | 7.08 Billion | 7.26 Billion |
Deferred income taxes | - | - | 2.03 Billion | -646.76 Million | 1.23 Billion | 1.98 Billion |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -6.87 Billion | 13.38 Billion | -16.87 Billion | 4.52 Billion | 1.2 Billion | 310.33 Million |
Other non-cash items | 627.36 Million | -19.9 Billion | 3.58 Billion | 4.27 Billion | 3.28 Billion | 3.91 Billion |
Investing Cash Flow | -20.62 Billion | -9.04 Billion | -43.33 Billion | -47.49 Billion | 23.34 Billion | -25.84 Billion |
Investments in PPE | -14.6 Billion | -32.1 Billion | -35.43 Billion | -48.68 Billion | -27.74 Billion | -7.99 Billion |
Acquisitions | 133.89 Thousand | 22.35 Billion | -29.58 Billion | 17.02 Billion | -22.01 Billion | 130.83 Million |
Investment purchases | -5.91 Billion | -154.8 Million | -171.52 Million | -17.35 Billion | -40.6 Million | -21.6 Billion |
Sales/Maturities of investments | 4769.00 | 22.04 Billion | 19.16 Billion | 1.21 Billion | 72.28 Billion | 2.73 Billion |
Other Investing Activities | -118.03 Million | -21.19 Billion | 2.68 Billion | 307.49 Million | 858.28 Million | 882.11 Million |
Financing Cash Flow | -15.38 Billion | -20.25 Billion | 8.24 Billion | 20.57 Billion | 8.12 Billion | 25.56 Billion |
Debt repayment | -8.71 Billion | -52.49 Billion | -14.88 Billion | -8.65 Billion | -12.07 Billion | -55.7 Billion |
Dividends payments | -5.24 Billion | -8.54 Billion | -2.65 Billion | -1.02 Billion | -4.38 Billion | -11 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 10.36 Billion | - | - | - | - |
Other Financing Activities | -1.42 Billion | 30.42 Billion | 25.78 Billion | 30.24 Billion | 24.58 Billion | 92.27 Billion |
Accounts receivables | 14.93 Billion | -5.43 Billion | -10.69 Billion | 9.7 Billion | 1.91 Billion | -2.06 Billion |
Accounts payables | -23.96 Billion | 51.16 Billion | 13.45 Billion | -15.44 Billion | 3.1 Billion | 2.97 Billion |
Inventory | 2.74 Billion | -16.32 Billion | -17.33 Billion | 7.58 Billion | -294.65 Million | 2.75 Billion |
Other working capital | -583.46 Million | -16.02 Billion | -2.29 Billion | 2.67 Billion | -3.52 Billion | -3.35 Billion |
Cash at beginning of period | 43.91 Billion | 29.69 Billion | 1.03 Billion | 2.86 Billion | -3.44 Billion | 15.62 Billion |
Cash at end of period | 28.43 Billion | 43.57 Billion | 29.69 Billion | 53.24 Billion | 74.85 Billion | 34.04 Billion |
Capital Expenditure | -14.6 Billion | -32.1 Billion | -35.43 Billion | -48.68 Billion | -27.74 Billion | -7.99 Billion |
Effect of forex changes on cash | -468.46 Million | -68.53 Million | 53.24 Billion | 74.85 Billion | 33.74 Billion | 385.69 Million |
Net cash flow / Change in cash | -15.48 Billion | 13.88 Billion | 28.65 Billion | 50.37 Billion | 78.3 Billion | 18.41 Billion |
Free Cash Flow | 6.39 Billion | 11.14 Billion | -24.93 Billion | -46.25 Billion | -14.66 Billion | 10.31 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 5.54 Billion | 5.86 Billion | 2.94 Billion | 19.44 Billion | 13.56 Billion | 618.35 Million |
Depreciation & Amortization | 2.12 Billion | 1.94 Billion | 2.01 Billion | 7.79 Billion | 1.94 Billion | 1.93 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 12.95 Billion | -2.99 Billion | 3.69 Billion | -6.87 Billion | -11.67 Billion | -10.65 Billion |
Other non-cash items | -10.28 Billion | 7.35 Billion | -3.13 Billion | 627.36 Million | 2.33 Billion | 1.78 Billion |
Investing Cash Flow | -7.2 Billion | -1.36 Billion | -4.3 Billion | -20.62 Billion | -7.19 Billion | -4.2 Billion |
Investments in PPE | -1.99 Billion | -4.29 Billion | -6.17 Billion | -14.6 Billion | -2.45 Billion | -1.91 Billion |
Acquisitions | - | - | 96.89 Thousand | 133.89 Thousand | - | - |
Investment purchases | -2.29 Billion | -10.25 Million | 1.98 Billion | -5.91 Billion | -4.82 Billion | -3.05 Billion |
Sales/Maturities of investments | -2.92 Billion | 2.92 Billion | -231.00 | 4769.00 | - | - |
Other Investing Activities | 7.04 Million | 12.33 Million | -110.93 Million | -118.03 Million | 86.16 Million | 759.09 Million |
Financing Cash Flow | -10.15 Billion | -954.49 Million | -711.53 Million | -15.38 Billion | -2.82 Billion | -4.32 Billion |
Debt repayment | -3.69 Billion | -782.53 Million | -75.6 Million | -8.71 Billion | -1.24 Billion | -11.64 Billion |
Dividends payments | -6.14 Billion | - | -402.00 | -5.24 Billion | -1.45 Billion | -3.79 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -29.27 Million | -4.12 Million | -635.92 Million | -1.42 Billion | -134.33 Million | 11.11 Billion |
Accounts receivables | -426.85 Million | 961.02 Million | -78.98 Million | 14.93 Billion | -6.94 Billion | 1.03 Billion |
Accounts payables | 18.11 Billion | -4.14 Billion | 6.09 Billion | -23.96 Billion | -1.63 Billion | -21.25 Billion |
Inventory | -5.06 Billion | 1.39 Billion | -1.08 Billion | 2.74 Billion | -5.04 Billion | 1.79 Billion |
Other working capital | 329.6 Million | -1.2 Billion | -1.24 Billion | -583.46 Million | 1.95 Billion | 7.77 Billion |
Cash at beginning of period | 33.38 Billion | 28.43 Billion | 28.32 Billion | 43.91 Billion | 32.59 Billion | 47.1 Billion |
Cash at end of period | 34.43 Billion | 33.38 Billion | 28.43 Billion | 28.43 Billion | 28.32 Billion | 32.59 Billion |
Capital Expenditure | -1.99 Billion | -4.29 Billion | -6.17 Billion | -14.6 Billion | -2.45 Billion | -1.91 Billion |
Effect of forex changes on cash | -293.86 Million | 781.39 Million | -401.41 Million | -468.46 Million | -414.45 Million | 345.11 Million |
Net cash flow / Change in cash | 1.04 Billion | 4.95 Billion | 102.36 Million | -15.48 Billion | -4.26 Billion | -14.5 Billion |
Free Cash Flow | 16.71 Billion | 2.2 Billion | -656.28 Million | 6.39 Billion | 3.71 Billion | -8.22 Billion |
BALPHARMA
DII-B
PDS
9225
HDYNQ
FSTR